Download Files:
Products Details
Product Description
– SARS-CoV-2 nsp14-IN-2 is a potent SARS-CoV-2 Nsp14 methyltransferase inhibitor with an IC50 value of 0.093 µM. SARS-CoV-2 nsp14-IN-2 shows antiviral activity. SARS-CoV-2 nsp14-IN-2 shows plasma and liver S9 stability. SARS-CoV-2 nsp14-IN-2 has the potential for the research of COVID-19[1].
Web ID
– HY-150681
Shipping
– Room temperature
Applications
– COVID-19-anti-virus
Molecular Formula
– C21H21N5O5S
References
– [1]Eunkyung Jung， et al. Bisubstate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. ACS Med. Chem. Lett. 2022.
CAS Number
– 2816165-16-7
Molecular Weight
– 455.49
SMILES
– O=S(C1=CC=C2C=CC=CC2=C1)(NC[C@H]3O[C@@H](C4=CC=C5C(N)=NC=NN54)[C@H](O)[C@@H]3O)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– SARS-CoV
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
